|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61F 2/02 | (2006.01) | ||
| A61K 31/5575 | (2006.01) | ||
| A61L 31/06 | (2006.01) | ||
| A61L 31/16 | (2006.01) | ||
| A61M 31/00 | (2006.01) | ||
| A61F 9/00 | (2006.01) |
| (11) | Patento numeris | 3290024 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17183171.2 |
| Europos patento paraiškos padavimo data | 2012-08-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161528736 P | 2011-08-29 | US | |
| 201261644397 P | 2012-05-08 | US |
| (72) |
CADDEN, Suzanne, CA
HAO, Yong, CA
UTKHEDE, Deepank, CA
RUBINCHIK, Valery, CA
KJELLBOTN, Charles Richard, CA
|
| (73) |
Mati Therapeutics Inc.,
4317 Dunning Lane, Austin, TX 78746,
US
|
| (54) | SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION |
| SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION |